Literature DB >> 15196470

RNA polymerase II structure: from core to functional complexes.

Patrick Cramer1.   

Abstract

New structural studies of RNA polymerase II (Pol II) complexes mark the beginning of a detailed mechanistic analysis of the eukaryotic mRNA transcription cycle. Crystallographic models of the complete Pol II, together with new biochemical and electron microscopic data, give insights into transcription initiation. The first X-ray analysis of a Pol II complex with a transcription factor, the elongation factor TFIIS, supports the idea that the polymerase has a 'tunable' active site that switches between mRNA synthesis and cleavage. The new studies also show that domains of transcription factors can enter polymerase openings, to modulate function during transcription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196470     DOI: 10.1016/j.gde.2004.01.003

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  30 in total

Review 1.  Dynamics of transcription and mRNA export.

Authors:  Xavier Darzacq; Robert H Singer; Yaron Shav-Tal
Journal:  Curr Opin Cell Biol       Date:  2005-06       Impact factor: 8.382

2.  In vivo dynamics of RNA polymerase II transcription.

Authors:  Xavier Darzacq; Yaron Shav-Tal; Valeria de Turris; Yehuda Brody; Shailesh M Shenoy; Robert D Phair; Robert H Singer
Journal:  Nat Struct Mol Biol       Date:  2007-08-05       Impact factor: 15.369

3.  Impact of template backbone heterogeneity on RNA polymerase II transcription.

Authors:  Liang Xu; Wei Wang; Lu Zhang; Jenny Chong; Xuhui Huang; Dong Wang
Journal:  Nucleic Acids Res       Date:  2015-02-06       Impact factor: 16.971

4.  Nonrandom variations in human cancer ESTs indicate that mRNA heterogeneity increases during carcinogenesis.

Authors:  Marie Brulliard; Dalia Lorphelin; Olivier Collignon; Walter Lorphelin; Benoit Thouvenot; Emmanuel Gothié; Sandrine Jacquenet; Virginie Ogier; Olivier Roitel; Jean-Marie Monnez; Pierre Vallois; Frances T Yen; Olivier Poch; Marc Guenneugues; Gilles Karcher; Pierre Oudet; Bernard E Bihain
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

5.  Variants in SCAF4 Cause a Neurodevelopmental Disorder and Are Associated with Impaired mRNA Processing.

Authors:  Anna Fliedner; Philipp Kirchner; Antje Wiesener; Irma van de Beek; Quinten Waisfisz; Mieke van Haelst; Daryl A Scott; Seema R Lalani; Jill A Rosenfeld; Mahshid S Azamian; Fan Xia; Marina Dutra-Clarke; Julian A Martinez-Agosto; Hane Lee; Grace J Noh; Natalie Lippa; Anna Alkelai; Vimla Aggarwal; Katherine E Agre; Ralitza Gavrilova; Ghayda M Mirzaa; Rachel Straussberg; Rony Cohen; Brooke Horist; Vidya Krishnamurthy; Kirsty McWalter; Jane Juusola; Laura Davis-Keppen; Lisa Ohden; Marjon van Slegtenhorst; Stella A de Man; Arif B Ekici; Anne Gregor; Ingrid van de Laar; Christiane Zweier
Journal:  Am J Hum Genet       Date:  2020-07-29       Impact factor: 11.025

Review 6.  Directed polymerase evolution.

Authors:  Tingjian Chen; Floyd E Romesberg
Journal:  FEBS Lett       Date:  2013-11-05       Impact factor: 4.124

Review 7.  Sub1/PC4, a multifaceted factor: from transcription to genome stability.

Authors:  Miguel Garavís; Olga Calvo
Journal:  Curr Genet       Date:  2017-05-31       Impact factor: 3.886

8.  Targeting tat inhibitors in the assembly of human immunodeficiency virus type 1 transcription complexes.

Authors:  Iván D'Orso; Jocelyn R Grunwell; Robert L Nakamura; Chandreyee Das; Alan D Frankel
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Human telomerase reverse transcriptase (hTERT) Q169 is essential for telomerase function in vitro and in vivo.

Authors:  Haley D M Wyatt; Allison R Tsang; Deirdre A Lobb; Tara L Beattie
Journal:  PLoS One       Date:  2009-09-24       Impact factor: 3.240

10.  Identification of a novel, widespread, and functionally important PCNA-binding motif.

Authors:  Karin M Gilljam; Emadoldin Feyzi; Per A Aas; Mirta M L Sousa; Rebekka Müller; Cathrine B Vågbø; Tara C Catterall; Nina B Liabakk; Geir Slupphaug; Finn Drabløs; Hans E Krokan; Marit Otterlei
Journal:  J Cell Biol       Date:  2009-09-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.